FOXP3 and neoplasm: Regarding the former aspect, we have demonstrated that Tconv proliferation was not required for their conversion into pTreg, since CD25+Foxp3+ cells could develop in tumor-bearing mice from CD25-depleted cells treated with an anti-proliferative agent (76).